文献速递消化内镜消化道肿瘤与早癌

结肠镜检查质量指标达成率随检查指征显著变化

Variation in Colonoscopy Performance Measures According to Procedure Indication.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-08-22

该多中心观察性横断面研究纳入西班牙14个中心14,867例结肠镜检查患者,按指征分为胃肠道症状(40.3%)、粪便免疫化学试验阳性(36.0%)、息肉切除后监测(15.3%)和原发筛查(8.4%)。以原发筛查为参照,胃肠道症状组肠道准备充分率和盲肠插管率更低,而粪便免疫化学试验阳性组和监测组腺瘤检出率更高,胃肠道症状组结直肠癌检出比例最高。结论认为结肠镜性能指标的达成率随指征显著变化,应制定筛查以外的质量指标政策并按指征调整基准。

要点

  • 胃肠道症状组肠道准备充分率83.1%,低于原发筛查组(OR 0.62,95%CI 0.49-0.78)。
  • 粪便免疫化学试验阳性组腺瘤检出率46.4%(OR 2.01,95%CI 1.71-2.35),高于原发筛查组。
  • 胃肠道症状组结直肠癌检出比例5.1%(OR 5.24,95%CI 2.30-11.93),为各组最高。

核心结论

  • 结肠镜性能指标的达成率随检查指征不同而存在实质性差异,基准建议可按指征调整。

主要发现

  • 胃肠道症状组肠道准备充分率83.1%,原发筛查组为参照(OR 0.62,95%CI 0.49-0.78)。
  • 息肉切除后监测组肠道准备充分率85.3%(OR 0.71,95%CI 0.55-0.91)。
  • 胃肠道症状组盲肠插管率93.1%(OR 0.34,95%CI 0.22-0.52)。
  • 粪便免疫化学试验阳性组腺瘤检出率46.4%(OR 2.01,95%CI 1.71-2.35),监测组48.2%(OR 1.41,95%CI 1.20-1.67)。
  • 胃肠道症状组结直肠癌检出比例5.1%(OR 5.24,95%CI 2.30-11.93),监测组最低为0.8%(OR 0.83,95%CI 0.32-2.14)。

临床怎么用

  • 临床解读结肠镜质量指标时应考虑检查指征,不宜直接套用原发筛查的基准。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Most fulfillment and benchmarking information for colonoscopy quality indicators has been obtained from studies of primary screening colonoscopies. We analyzed differences in the fulfillment of colonoscopy quality indicators based on the indication for endoscopy. METHODS: We performed an observational, multicenter, cross-sectional study of 14,867 patients who underwent endoscopy procedures for gastrointestinal symptoms (40.3%), a positive result from a fecal immunochemical test (36.0%), postpolypectomy surveillance (15.3%), or primary screening (8.4%), from February 2016 through December 2017 at 14 centers in Spain. We evaluated rates of adequate colon cleansing, cecal intubation, adenoma detection, and colorectal cancer detection, among others. We used findings from primary screening colonoscopies as the reference standard. RESULTS: Fewer than 90% of patients had adequate bowel preparation; 83.1% of patients with gastrointestinal symptoms had adequate bowel preparation (odds ratio [OR] compared with patients with primary screening colonoscopies, 0.62; 95% CI, 0.49-0.78) and 85.3% of patients receiving postpolypectomy surveillance had adequate bowel preparation (OR, 0.71; 95% CI, 0.55-0.91). The cecal intubation rate was also lower in patients with gastrointestinal symptoms (93.1%) (OR, 0.34; 95% CI, 0.22-0.52). The adenoma detection rate was higher in patients with a positive result from a fecal immunochemical test (46.4%) (OR, 2.01; 95% CI, 1.71-2.35) and in patients undergoing postpolypectomy surveillance (48.2%) (OR, 1.41; 95% CI, 1.20-1.67). The highest proportion of patients with colorectal cancer was in the gastrointestinal symptom group (5.1%) (OR, 5.24; 95% CI, 2.30-11.93) and the lowest was in patients undergoing surveillance (0.8%) (OR, 0.83; 95% CI, 0.32-2.14). CONCLUSIONS: Fulfillment of colonoscopy performance measures varies substantially by indication. Policies addressing performance measures beyond colonoscopy screening procedures should be developed. Benchmarking recommendations could be adjusted according to colonoscopy indication.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Mangas-Sanjuan C, Santana E, Cubiella J, et al. Variation in Colonoscopy Performance Measures According to Procedure Indication. Clin Gastroenterol Hepatol. 2019. PMID: 31446179. doi:10.1016/j.cgh.2019.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。